These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Socioeconomic Disparities in the Presentation and Treatment of Graves' Disease and Thyroid Eye Disease. Vargason CW; Chelnis JG; Barahimi BI; Mawn LA Semin Ophthalmol; 2016; 31(4):409-14. PubMed ID: 27385363 [TBL] [Abstract][Full Text] [Related]
15. [Management of moderate and severe dysthyroid orbitopathy: about 22 cases]. Daldoul N; Knani L; Gatfaoui F; Mahjoub H Pan Afr Med J; 2017; 27():257. PubMed ID: 29187926 [TBL] [Abstract][Full Text] [Related]
19. Current and Emerging Treatment Strategies for Graves' Orbitopathy. Genere N; Stan MN Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423 [TBL] [Abstract][Full Text] [Related]
20. Treatment of moderate to severe orbitopathy: Current modalities and perspectives. Bouzehouane N; Borson-Chazot F; Abeillon J; Caron P Ann Endocrinol (Paris); 2021 Apr; 82(2):92-98. PubMed ID: 33676921 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]